News – Page 144 – Endpoints News

J&J’s Sjögren’s disease drug shows promise in Phase 2, boosts prospects of FcRn assets in the autoimmune disease

11 months ago

Marinus reports mixed Phase 3 results on IV seizure drug

11 months ago

Aerovate’s stock craters after PAH drug fails Phase 2 study

11 months ago

It’s time to nominate your favorite private biotech for this year’s Endpoints 11

11 months ago

Deerfield backs $81M round for biotech developing antifungal therapy with less toxicity

11 months ago

Updated: Takeda’s Ovid-licensed drug fails two Phase 3 epilepsy studies

11 months ago

Nurix’s protein degrader overcomes resistance to BTK mutations in small leukemia study

11 months ago

With new data, AstraZeneca makes the case for its BTK inhibitor in a first-line setting

11 months ago

Gilead cancer drug magrolimab showed worrying trends around death

11 months ago

BIO CEO’s patriotic pivot; Step forward for Lilly’s Alzheimer’s drug; Pfizer’s gene therapy setback; ...

11 months ago

FDA asks Covid-19 vaccine makers to instead target KP.2 strain for fall season

11 months ago

Ending 'product hopping' and other patent changes could save US $3B over a decade, CBO says

11 months ago

Rare pediatric disease vouchers face uncertain future after September

11 months ago

Vaxart wins $453M in BARDA funding for oral Covid-19 vaccine

11 months ago

Autoimmune CAR-T data dump: Kyverna, Cabaletta shares fall after unveiling early-stage results

11 months ago

Takeda signs option deal for TKI inhibitor; Enveda's $55M raise

11 months ago

Stephen Squinto talks writing checks and next-gen obesity drugs as JP Morgan closes first $500M+ biotech fund

11 months ago

Roche details Columvi OS data in quest for expanded lymphoma approval

11 months ago

Innovent details Phase 3 weight loss data from Lilly-partnered GLP-1 in Chinese patients

11 months ago

Bill Haney gives up CEO post at Skyhawk, becomes chairman; Bayer parts ways with head of biotech

11 months ago

AI drug discovery startup goes public in Hong Kong, nabbing $115M to build on pharma partnerships

11 months ago

Updated: Telix Pharmaceuticals pulls Nasdaq listing plans just before trading was to start

11 months ago

Bristol Myers' cancer drug Augtyro wins new accelerated approval in solid tumors

11 months ago

Stakeholders weigh in on potential reforms to FDA advisory committee process

11 months ago

First page Previous page 141 142 143144145 146 147 Next page Last page